SLDB RA Capital Healthcare Fund LP buys $15.0M worth of shares
Feb 22, 2025, 5:33 AM
-16.44%
What does SLDB do
Solid Biosciences, headquartered in Charlestown, Massachusetts, develops gene therapies for Duchenne muscular dystrophy and other cardiac diseases, employing 88 staff since its IPO on January 26, 2018. Their pipeline includes multiple gene therapy candidates and novel platform technologies.
RA Capital Healthcare Fund LP bought 3,722,085 shares of SLDB on 19 February at $4.03 per share, worth a total of $15.0M. They now own 3,722,085 SLDB shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
